Molecular Mechanisms of Disease Progression in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type during Ibrutinib Therapy

Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL-LT) is one of the well-recognized extranodal lymphomas commonly addicted to the B-cell receptor-MYD88 superpathway. We aimed to describe the genomic changes in a patient who progressed through treatment with ibrutinib, a Bruton’s tyr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Mol Sci
Autors principals: Fox, Lucy C., Yannakou, Costas K., Ryland, Georgina, Lade, Stephen, Dickinson, Michael, Campbell, Belinda A., Prince, Henry Miles
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2018
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6032268/
https://ncbi.nlm.nih.gov/pubmed/29899297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19061758
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars